MX2018004246A - Dispositivo para administracion transdermal de buprenorfina. - Google Patents

Dispositivo para administracion transdermal de buprenorfina.

Info

Publication number
MX2018004246A
MX2018004246A MX2018004246A MX2018004246A MX2018004246A MX 2018004246 A MX2018004246 A MX 2018004246A MX 2018004246 A MX2018004246 A MX 2018004246A MX 2018004246 A MX2018004246 A MX 2018004246A MX 2018004246 A MX2018004246 A MX 2018004246A
Authority
MX
Mexico
Prior art keywords
buprenorphine
transdermal delivery
adhesive matrix
adhesive
acrylic polymer
Prior art date
Application number
MX2018004246A
Other languages
English (en)
Inventor
Fabio Scasso Alejandro
José Evaristo Stefano Francisco
Original Assignee
Amarin Tech S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Tech S A filed Critical Amarin Tech S A
Publication of MX2018004246A publication Critical patent/MX2018004246A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un dispositivo para la administración transdermal de buprenorfina que comprende una matriz adhesiva, una lámina de soporte y una lámina de despegue, en donde la matriz adhesiva comprende un polímero acrílico adhesivo no entrecruzado y sin funcionalidad carboxílica, Buprenorfina Base, ácido levulínico y Miristato de isopropilo.
MX2018004246A 2015-10-08 2016-10-07 Dispositivo para administracion transdermal de buprenorfina. MX2018004246A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP150103253A AR102214A1 (es) 2015-10-08 2015-10-08 Un dispositivo para la administración transdermal de buprenorfina
PCT/EP2016/074072 WO2017060472A1 (en) 2015-10-08 2016-10-07 A device for the transdermal delivery of buprenorphine

Publications (1)

Publication Number Publication Date
MX2018004246A true MX2018004246A (es) 2018-06-27

Family

ID=58487101

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018004246A MX2018004246A (es) 2015-10-08 2016-10-07 Dispositivo para administracion transdermal de buprenorfina.

Country Status (6)

Country Link
US (1) US20190117585A1 (es)
EP (1) EP3359143A1 (es)
AR (1) AR102214A1 (es)
CA (1) CA3000891A1 (es)
MX (1) MX2018004246A (es)
WO (1) WO2017060472A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115884763A (zh) * 2020-08-19 2023-03-31 东洋油墨Sc控股株式会社 贴附剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
DK2640389T3 (en) * 2010-11-17 2015-03-09 Hexal Ag Transdermal therapeutic system comprising buprenorphine
ES2802050T3 (es) * 2012-11-14 2021-01-15 Abon Pharmaceuticals Llc Sistema de administración de fármacos por vía transmucosa oral
CA2914425C (en) * 2013-06-04 2019-09-17 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system

Also Published As

Publication number Publication date
US20190117585A1 (en) 2019-04-25
CA3000891A1 (en) 2017-04-13
WO2017060472A1 (en) 2017-04-13
AR102214A1 (es) 2017-02-15
EP3359143A1 (en) 2018-08-15

Similar Documents

Publication Publication Date Title
SG11202001188TA (en) Pressure-sensitive adhesive composition for organic el display device, pressure-sensitive adhesive layer for organic el display device, pressure-sensitive adhesive layer attached polarizing film for organic el display devices, and organic el display device
EP3195163A4 (en) System and method for detecting activation of a medical delivery device
TW201611859A (en) Microneedle device
EP3054816A4 (en) Article support using peel release adhesives
MX2010002452A (es) Sistema de entrega de medicamento transdermico que comprende una capa de liberacion recubierta.
MX2017003623A (es) Parche de opipramol.
UA114101C2 (xx) Трансдермальна терапевтична система для введення фентанілу або його аналога
EP3873494A4 (en) Biodegradable microneedles for transdermal therapeutic agent delivery
EP3664885A4 (en) TRANSDERMAL DRUG DELIVERY SYSTEM
MX2016011744A (es) Soluciones de buprenorfina de liberacion sostenida.
EP3415141A4 (en) ULTRAVIOLET-CURING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL DELIVERY, AND CATAPLASM AGENT COMPRISING THE SAME
PH12015502280A1 (en) Transdermal delivery system comprising donepezil or its salt
AR095258A1 (es) Composiciones transdérmicas de metilfenidato con adhesivos a base de goma
MY179230A (en) Ketoprofen-containing poultice
EP3691641A4 (en) DEXTROMETHORPHANE DEVICE FOR TRANSDERMAL ADMINISTRATION
EP3614916A4 (en) SINGLE IMPLANTABLE DEVICE IDENTIFIER AND DETECTION SYSTEM
EP3880175A4 (en) TEMPERATURE-REGULATING TRANSDERMAL DRUG DELIVERY SYSTEM
CY1123202T1 (el) Σκευασμα υδροκορτιζονης ελεγχομενης απελευθερωσης
BR112017001764A2 (pt) método, e, aparelho
EP3694497C0 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL DELIVERY OF GUANFACIN WITH A SILICONE-ACRYLIC HYBRID POLYMER
MX2020003665A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo.
MX2020003667A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero de silicona.
EP3012574B8 (de) Einrichtung zur steuerbaren druckentlastung eines wirksystems
TW201613582A (en) Adhesive patch
EP3338175A4 (en) Method and system for prompt message display